Test Code LACS1 Lactate, Plasma
Ordering Guidance
This test does not measure D-lactate, an uncommon, often undiagnosed cause of lactic acidosis. If D-lactate testing is needed, order DLAC / D-Lactate, Plasma.
Necessary Information
Patient's age and sex are required.
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Gray top (potassium oxalate/sodium fluoride)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.625 mL Plasma
Collection Instructions:
1. Draw at least 1 mL whole blood in a 2-mL collection tube or at least 2 mL whole blood in a 4-mL collection tube.
2. Centrifuge and aliquot plasma into a plastic vial.
Useful For
Diagnosing and monitoring patients with lactic acidosis
Screening high-risk patients for sepsis or septic shock
Method Name
Enzymatic Colorimetric
Reporting Name
Lactate, PSpecimen Type
Plasma NaFl-KOxSpecimen Minimum Volume
Plasma: 0.25 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Plasma NaFl-KOx | Refrigerated (preferred) | 14 days |
| Ambient | 8 hours |
Reject Due To
| Gross hemolysis | Reject |
Clinical Information
Lactate is the end product of anaerobic carbohydrate metabolism and increases with prolonged exercise. Major sites of production are skeletal muscle, brain, and erythrocytes. Lactate is metabolized by the liver. The concentration of lactate depends on the rate of production and the rate of liver clearance. The liver can adequately clear lactate until the concentration reaches approximately 2.0 mmol/L. When this level is exceeded, lactate begins to accumulate rapidly. For example, while resting lactate levels are usually below 1 mmol/L, during strenuous exercise, levels can rise above 20 mmol/L within a few seconds.
Lactic acidosis signals the deterioration of the cellular oxidative process and is associated with hyperpnea, weakness, fatigue, stupor, and finally coma. These conditions may be irreversible, even after treatment is administered. Lactate acidosis may be associated with hypoxic conditions (eg, shock, hypovolemia, heart failure, pulmonary insufficiency), metabolic disorders (eg, diabetic ketoacidosis, malignancies), and toxin exposures (eg, ethanol, methanol, salicylates).
Reference Values
0-2 months: ≤3.3 mmol/L
3-24 months: ≤3.1 mmol/L
25 months-17 years: ≤2.2 mmol/L
> or 18 years: 0.5-2.0 mmol/L*
*Further information regarding the adult clinical action limit is available:
Townsend SR, Phillips GS, Duseja R, et al. Effects of compliance with the early management bundle (SEP-1) on mortality changes among medicare beneficiaries with sepsis: A propensity score matched cohort study. Chest. 2022;161(2):392-406. doi:10.1016/j.chest.2021.07.2167
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
83605